Loading clinical trials...
Loading clinical trials...
Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma
Conditions
Interventions
Temsirolimus
Sorafenib:
Locations
2
United States
University of California, San Francisco
San Francisco, California, United States
Robert H Lurie Comprehensive Cancer Center
Chicago, Illinois, United States
Start Date
October 5, 2012
Primary Completion Date
April 26, 2016
Completion Date
January 9, 2020
Last Updated
December 7, 2020
NCT07175441
NCT05969860
NCT06427941
NCT05842174
NCT07164313
NCT07118202
Lead Sponsor
University of California, San Francisco
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions